drugset / Trial / NCT01198834

MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains

NCT01198834

Phase 3 Completed 600 enrolled MEDRx USA, Inc.
RandomizedFactorialDouble-blindTreatment

Summary

A Randomized, Multi-Center, Double-Blind, Factorial, Comparator and Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains

Timeline

Start
2010-09
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Etodolac Unknown Topical
Subject Lidocaine Other / unclassified Topical
Subject MRX-7EAT Unknown Topical

Indications

No indication recorded.